The Biotech Growth Trust PLC (BIOG)
Category Sector Equity Biotechnology
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
634.00p
Buy
680.00p
20.00p (+3.23%)
Discount/Premium
-15.37%
Estimated NAV
732.60p
Prices updated at 10 Apr 2025, 16:35 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
Annual performance (%)
Year | This fund | Peer group index |
|---|---|---|
| 31 Mar 14 - 31 Mar 15 | 69.91 | 60.17 |
| 31 Mar 15 - 31 Mar 16 | -26.28 | -16.73 |
| 31 Mar 16 - 31 Mar 17 | 27.86 | 32.18 |
| 31 Mar 17 - 31 Mar 18 | -6.15 | -15.18 |
| 31 Mar 18 - 31 Mar 19 | 4.56 | 5.98 |
| 31 Mar 19 - 31 Mar 20 | 10.90 | 36.22 |
| 31 Mar 20 - 31 Mar 21 | 75.18 | 49.11 |
| 31 Mar 21 - 31 Mar 22 | -37.03 | -15.25 |
| 31 Mar 22 - 31 Mar 23 | -12.81 | -7.08 |
| 31 Mar 23 - 31 Mar 24 | 27.08 | 15.32 |
| 31 Mar 24 - 31 Mar 25 | -24.22 | -21.04 |
Primary benchmark: NASDAQ Biotechnology TR GBP
Peer group index: Morningstar IT Biotechnology & Healthcare
Trailing returns (%)
Year | This fund | Peer group index |
|---|---|---|
| 1 Day | -6.91 | -3.86 |
| 1 Month | -22.01 | -16.02 |
| 3 Months | -27.14 | -20.60 |
| 6 Months | -38.98 | -28.13 |
| 1 Year | -35.88 | -27.95 |
| 3 Years annualised | -12.95 | -9.71 |
| 5 Years annualised | -6.76 | -1.94 |
Primary benchmark: NASDAQ Biotechnology TR GBP
Peer group index: Morningstar IT Biotechnology & Healthcare
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
